Journal
NEW JOURNAL OF CHEMISTRY
Volume 37, Issue 7, Pages 1944-1949Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3nj00168g
Keywords
-
Categories
Funding
- Australian Research Council (ARC)
- National Health & Medical Research Council (NHMRC)
Ask authors/readers for more resources
Chondroitinase ABC (chABC) has evolved as a promising therapeutic for the degradation of inhibitory chondroitin sulfate proteoglycans (CSPGs) after injury to the central nervous system (CNS). The enzymatic breakdown of CSPGs by administered chABC reinstated plasticity as well as axon regeneration; leading to improved CNS recovery. Thus, in an effort to develop and evaluate treatments of CNS injury utilising chABC, the accurate detection of levels of CSPGs and more importantly activity of chABC is of paramount importance. Here we present a spectrophotometric assay suitable for accurately and quantitatively measuring chABC activity, based on the use of 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1). This novel WST-1 based assay was compared to two other assays: measurement of alkene generation at 232 nm and a 1,9 dimethyl methylene blue (DMMB) assay which have been used previously for the detection of chABC activity and CSPGs respectively. Comparison of these assays demonstrated that the WST-1 assay was quantitative, efficient, cheap and easy to perform and overall was superior in the detection of chABC activity at all concentrations when compared to the other methods tested.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available